Editorial Board Member

Matthias Ocker
Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Campus, Charité Mitte, Charité University Medicine Berlin, Berlin, Germany.
HomePage
Research Interests:
drug discovery and development, precision medicine for HCC and CCA, cell death pathways, early clinical trials, biomarkers
Special Issue:

Novel Prognostic Marker and Potential Target for HCC

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/